Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer

Samson, A orcid.org/0000-0002-3081-7850, Bentham, MJ orcid.org/0000-0003-2439-3198, Scott, K orcid.org/0000-0002-5790-9579 et al. (15 more authors) (2018) Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer. Gut, 67 (3). pp. 562-573. ISSN 0017-5749

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
Keywords: Oncolytic virus; immunotherapy; hepatitis C virus; hepatocellular carcinoma; Reovirus
Dates:
  • Published: March 2018
  • Accepted: 13 October 2016
  • Published (online): 15 November 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP)
Depositing User: Symplectic Publications
Date Deposited: 18 Oct 2016 10:09
Last Modified: 19 Apr 2018 08:36
Status: Published
Publisher: BMJ Publishing Group
Identification Number: https://doi.org/10.1136/gutjnl-2016-312009

Download

Share / Export

Statistics